Archived Newsletters

1. 06.19.19 -- Ranbaxy Revisited: Why We Need To Look Back
   6/19/2019
   06/19/19 Outsourced Pharma Newsletter
2. 06.18.19 -- Process Development And Regulatory Guidance For Today's Biomanufacturing Challenges
   6/18/2019
   06/18/19 Outsourced Pharma Newsletter
3. 06.12.19 -- 10 Questions For "Make Vs. Buy" In Drug Development And Manufacturing
   6/12/2019
   06/12/19 Outsourced Pharma Newsletter
4. 06.11.19 -- Answering Today's Pharma Dilemma Of Build Or Buy
   6/11/2019
   06/11/19 Outsourced Pharma Newsletter
5. 06.07.19 -- Do You Have The Right Tools To Determine CQA?
   6/7/2019
   06/07/19 Outsourced Pharma Newsletter
6. 06.06.19 -- Updates From Thermo Fisher Scientific - Acquisitions And Capabilities
   6/6/2019
   06/06/19 Outsourced Pharma Newsletter
7. 06.05.19 -- Novartis And The Price Of A Child's Life
   6/5/2019
   06/05/19 Outsourced Pharma Newsletter
8. 05.31.19 -- The Challenges Of Biopharmaceutical Quality
   5/31/2019
   05/31/19 Outsourced Pharma Newsletter
9. 05.29.19 -- The Remarkable Rise Of Japan's CDMOs
   5/29/2019
   05/29/19 Outsourced Pharma Newsletter
10. 05.28.19 -- Optimizing API Development And Manufacturing
    5/28/2019
    05/28/19 Outsourced Pharma Newsletter